MCCM MEDICAL COSMETICS references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
MCCM Medical Cosmetics HA SENSEI II
MCCM HA SENSEI II is an injectable dermal filler from the MCCM MEDICAL COSMETICS brand (manufacturer Mesosystem S.A., Portugal), developed to restore facial volume and to reduce the severity and volume of wrinkles. It is suitable for qualified practitioners only, for professional use, with clinical data supporting its use in the nasolabial folds. The product is a sterile, non-pyrogenic, bioabsorbable gel of cross-linked hyaluronic acid at 20 mg/mL, made from non-animal hyaluronic acid that is produced by Streptococcus equi fermentation and cross-linked with BDDE. Sterile single-use needles (23G or 27G) are required and are not included.
*Note: This product has market-specific regulatory status. Please contact ALLPARA to confirm current certification and availability for your market before ordering.
Key Benefits of MCCM Medical Cosmetics HA SENSEI II
- Cross-linked hyaluronic acid dermal filler (20 mg/mL, BDDE, non-animal origin)
- Restores facial volume and redefines facial contours
- Reduces the severity and volume of wrinkles in the nasolabial folds
- Sterile, non-pyrogenic, bioabsorbable gel in a 1 mL prefilled syringe
- Expected duration of approximately 12 months
Indications and Professional Use
Main indications
- Nasolabial folds - reduction of wrinkle severity and volume
- Facial volume restoration
- Management of facial ageing
Professional use
MCCM HA SENSEI 2 is intended strictly for professional use by qualified aesthetic practitioners. It is a Class III injectable dermal filler administered by injection into the mid-dermis of the nasolabial folds using a sterile single-use needle (23G or 27G, not included); clinical data support up to 1 mL per side per session, not exceeding 2 mL per patient per session. It is used in a hospital or private medical office with appropriate aseptic facilities. It is indicated for adults aged 35 and over and must not be used in anyone under 35 or in pregnant or breastfeeding women. Contraindications include known hypersensitivity to hyaluronic acid or streptococcal proteins, allergy to the anaesthetic used, active infection or inflammation at the injection site, autoimmune disease or a history of streptococcal disease, ongoing anticoagulant or immunosuppressive therapy, and more.
Treatment areas
- Nasolabial folds
Patient profile
Adults aged 35 and over; not for use in anyone under 35 or in pregnant or breastfeeding women. Clinical data are limited in patients older than 65, with Fitzpatrick skin phototypes V and VI, with wrinkles graded below 2 on the Modified Fitzpatrick Wrinkle Scale, with scars, moles or sunburn close to the nasolabial folds, or who have had or will have another aesthetic treatment close to the nasolabial folds; use with caution in these patients.
How MCCM Medical Cosmetics HA SENSEI II Works
MCCM HA SENSEI 2 is a cross-linked hyaluronic acid gel (20 mg/mL, BDDE cross-linked, non-animal origin). Once injected, it restores lost volume in the tissue to redefine facial contours and to reduce the severity and volume of wrinkles. The gel is bioabsorbable, with an expected duration of approximately 12 months. After 1 mL per nasolabial fold in one session, improvement was still noticeable at 12 months, with a reduction in fold volume versus baseline in 65.52% of subjects.
Why Order From Allpara
Allpara offers genuine, verified MCCM MEDICAL COSMETICS products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
Is MCCM HA SENSEI 2 injected or applied topically?
It is an injectable dermal filler. MCCM HA SENSEI 2 is administered by a qualified practitioner using a sterile single-use needle (23G or 27G), not applied topically.
Who can be treated with MCCM HA SENSEI 2?
Adults aged 35 and over. It must not be used in people under 35 or in pregnant or breastfeeding women.
More from Mesosystem
Clinic alternatives
Pick up where you left off
MCCM Medical Cosmetics HA SENSEI II
MCCM HA SENSEI II is an injectable dermal filler from the MCCM MEDICAL COSMETICS brand (manufacturer Mesosystem S.A., Portugal), developed to restore facial volume and to reduce the severity and volume of wrinkles. It is suitable for qualified practitioners only, for professional use, with clinical data supporting its use in the nasolabial folds. The product is a sterile, non-pyrogenic, bioabsorbable gel of cross-linked hyaluronic acid at 20 mg/mL, made from non-animal hyaluronic acid that is produced by Streptococcus equi fermentation and cross-linked with BDDE. Sterile single-use needles (23G or 27G) are required and are not included.
*Note: This product has market-specific regulatory status. Please contact ALLPARA to confirm current certification and availability for your market before ordering.
Key Benefits of MCCM Medical Cosmetics HA SENSEI II
- Cross-linked hyaluronic acid dermal filler (20 mg/mL, BDDE, non-animal origin)
- Restores facial volume and redefines facial contours
- Reduces the severity and volume of wrinkles in the nasolabial folds
- Sterile, non-pyrogenic, bioabsorbable gel in a 1 mL prefilled syringe
- Expected duration of approximately 12 months
Indications and Professional Use
Main indications
- Nasolabial folds - reduction of wrinkle severity and volume
- Facial volume restoration
- Management of facial ageing
Professional use
MCCM HA SENSEI 2 is intended strictly for professional use by qualified aesthetic practitioners. It is a Class III injectable dermal filler administered by injection into the mid-dermis of the nasolabial folds using a sterile single-use needle (23G or 27G, not included); clinical data support up to 1 mL per side per session, not exceeding 2 mL per patient per session. It is used in a hospital or private medical office with appropriate aseptic facilities. It is indicated for adults aged 35 and over and must not be used in anyone under 35 or in pregnant or breastfeeding women. Contraindications include known hypersensitivity to hyaluronic acid or streptococcal proteins, allergy to the anaesthetic used, active infection or inflammation at the injection site, autoimmune disease or a history of streptococcal disease, ongoing anticoagulant or immunosuppressive therapy, and more.
Treatment areas
- Nasolabial folds
Patient profile
Adults aged 35 and over; not for use in anyone under 35 or in pregnant or breastfeeding women. Clinical data are limited in patients older than 65, with Fitzpatrick skin phototypes V and VI, with wrinkles graded below 2 on the Modified Fitzpatrick Wrinkle Scale, with scars, moles or sunburn close to the nasolabial folds, or who have had or will have another aesthetic treatment close to the nasolabial folds; use with caution in these patients.
How MCCM Medical Cosmetics HA SENSEI II Works
MCCM HA SENSEI 2 is a cross-linked hyaluronic acid gel (20 mg/mL, BDDE cross-linked, non-animal origin). Once injected, it restores lost volume in the tissue to redefine facial contours and to reduce the severity and volume of wrinkles. The gel is bioabsorbable, with an expected duration of approximately 12 months. After 1 mL per nasolabial fold in one session, improvement was still noticeable at 12 months, with a reduction in fold volume versus baseline in 65.52% of subjects.
Why Order From Allpara
Allpara offers genuine, verified MCCM MEDICAL COSMETICS products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
Is MCCM HA SENSEI 2 injected or applied topically?
It is an injectable dermal filler. MCCM HA SENSEI 2 is administered by a qualified practitioner using a sterile single-use needle (23G or 27G), not applied topically.
Who can be treated with MCCM HA SENSEI 2?
Adults aged 35 and over. It must not be used in people under 35 or in pregnant or breastfeeding women.